These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11529764)

  • 21. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
    Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents.
    Biftu T; Feng D; Fisher M; Liang GB; Qian X; Scribner A; Dennis R; Lee S; Liberator PA; Brown C; Gurnett A; Leavitt PS; Thompson D; Mathew J; Misura A; Samaras S; Tamas T; Sina JF; McNulty KA; McKnight CG; Schmatz DM; Wyvratt M
    Bioorg Med Chem Lett; 2006 May; 16(9):2479-83. PubMed ID: 16464591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.
    Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
    Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
    Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-parasitic activity of depudecin on Neospora caninum via the inhibition of histone deacetylase.
    Kwon HJ; Kim JH; Kim M; Lee JK; Hwang WS; Kim DY
    Vet Parasitol; 2003 Mar; 112(4):269-76. PubMed ID: 12623206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and characterization of histone deacetylase from Babesia bovis.
    Munkhjargal T; Aboulaila M; Ueno A; Sivakumar T; Nakano Y; Yokoyama M; Yokoyama N; Igarashi I
    Vet Parasitol; 2012 Dec; 190(3-4):423-33. PubMed ID: 22818786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase: a target for antiproliferative and antiprotozoal agents.
    Meinke PT; Liberator P
    Curr Med Chem; 2001 Feb; 8(2):211-35. PubMed ID: 11172676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
    Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent Access to Histone Deacetylase Inhibitory Cyclopeptides via a Late-Stage Cyclopropane Ring Cleavage Strategy. Short Synthesis of Chlamydocin.
    Elek GZ; Koppel K; Zubrytski DM; Konrad N; Järving I; Lopp M; Kananovich DG
    Org Lett; 2019 Oct; 21(20):8473-8478. PubMed ID: 31596600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors.
    Guerrant W; Mwakwari SC; Chen PC; Khan SI; Tekwani BL; Oyelere AK
    ChemMedChem; 2010 Aug; 5(8):1232-5. PubMed ID: 20533500
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
    Patil V; Guerrant W; Chen PC; Gryder B; Benicewicz DB; Khan SI; Tekwani BL; Oyelere AK
    Bioorg Med Chem; 2010 Jan; 18(1):415-25. PubMed ID: 19914074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.
    Singh EK; Ravula S; Pan CM; Pan PS; Vasko RC; Lapera SA; Weerasinghe SV; Pflum MK; McAlpine SR
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2549-54. PubMed ID: 18381239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum.
    Brosch G; Ransom R; Lechner T; Walton JD; Loidl P
    Plant Cell; 1995 Nov; 7(11):1941-50. PubMed ID: 8535144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogues of the cytostatic and antimitogenic agents chlamydocin and HC-toxin: synthesis and biological activity of chloromethyl ketone and diazomethyl ketone functionalized cyclic tetrapeptides.
    Shute RE; Dunlap B; Rich DH
    J Med Chem; 1987 Jan; 30(1):71-8. PubMed ID: 3806605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells.
    Noh JH; Song JH; Eun JW; Kim JK; Jung KH; Bae HJ; Xie HJ; Ryu JC; Ahn YM; Wee SJ; Park WS; Lee JY; Nam SW
    Int J Mol Med; 2009 Aug; 24(2):205-26. PubMed ID: 19578794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Structure-activity relationships of histone deacetylase inhibitors].
    Tan YM; Huang WY; Yu NF
    Yao Xue Xue Bao; 2009 Oct; 44(10):1072-83. PubMed ID: 20055127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin.
    Kim YK; Seo DW; Kang DW; Lee HY; Han JW; Kim SN
    Biochem Biophys Res Commun; 2006 Sep; 347(4):1088-93. PubMed ID: 16870149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.